All GP articles – Page 12
-
![20210603 Guidelines comparison table [online]](data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAMAAAACCAQAAAA3fa6RAAAADklEQVR42mNkAANGCAUAACMAA2w/AMgAAAAASUVORK5CYII=)
Independent professional body guidelineType 2 diabetes pharmacological management pathway comparison
This comparison table summarises recommendations on the management of hyperglycaemia in adults with type 2 diabetes from ADA/EASD, NICE, and SIGN
-
NICE guideline
NICE heavy menstrual bleeding guideline
Includes recommendations on management and investigations on the causes of heavy menstrual bleeding, also covering history taking, diagnosis, and provision of information
-
Independent professional body guideline
GINA strategy 2021: management of asthma
This Guidelines summary outlines recommendations for the management of asthma in adults, adolescents, and children aged 6–11
-
News
One-dose Janssen COVID vaccine approved by MHRA
The vaccine is the first single-dose COVID-19 vaccine to be approved for use in the UK
-
NICE guideline
NICE epilepsy guideline
A brief, helpful summary of the diagnosis and management of epilepsy in adults and children. Includes status epilepticus management, review, and referral
-
NICE guideline
NICE headache guideline
This easy-to-read summary of NICE's guideline explores the diagnosis and management of tension, migraine, cluster, and medication overuse headaches
-
News
SIGN publishes new guideline on epilepsies in children
The new clinical guideline contains recommendations on the investigation and management of epilepsies in children
-
News
Updated guidance on headaches in over 12s published by NICE
NICE has updated its guideline on headaches in over 12s to include the needs of women and girls of reproductive age
-
News
MHRA updates guidance on licensing of biosimilars
Updated guidance on the licensing of biosimiar products, based on the current European Medicines Agency biosimilar guidance, has been published by the MHRA
-
News
New drug that halves cancer recurrence risk to be offered by NHS
NHS England is to roll out a new drug which halves the risk of cancer for patients dealing with a return of the disease after undergoing treatment
-
News
GINA updates global strategy for asthma management and prevention
The update to GINA’s 2021 report contains updated treatment recommendations, and new advice about COVID-19 and asthma
-
Independent professional body guideline
CaReMeUK heart failure algorithm
A heart failure management algorithm modified from the NICE guideline, Chronic heart failure in adults: diagnosis and management
-
Independent professional body guideline
CaReMeUK cardiovascular risk optimisation algorithm
A guide for non-diabetes specialist physicians and primary care teams for cardiovascular risk optimisation in patients with type 2 diabetes and atherosclerotic cardiovascular disease
-
News
NICE publishes new atrial fibrillation guideline
NICE’s new guideline Atrial fibrillation: diagnosis and management updates and replaces NICE guideline CG180, and includes recommendations for providing the best care and treatment for adults with atrial fibrillation
-
NICE guideline
NICE chronic pain guideline
A summary of guidance to assist healthcare professionals on the diagnosis and management of chronic pain in over 16s
-
NICE guideline
NICE asthma guideline: chronic asthma management
A practical summary of NICE recommendations on managing chronic asthma in children, young people, and adults, including three management algorithms
-
NICE guideline
NICE secondary bacterial infection of common skin conditions
This Guidelines summary covers an antimicrobial prescribing strategy for secondary bacterial infection of eczema and covers infection of other common skin conditions
-
News
NICE sets out new 5-year strategy
NICE’s new strategy to 2026 sets out the institute’s ambitious vision for the future
-
NICE guideline
NICE asthma guideline: diagnosis and monitoring
A concise summary on the initial assessment, diagnosis, and monitoring of asthma in adults, young people, and children. Includes assessment algorithms
-
NICE guideline
COVID-19 rapid guideline on gastrointestinal and liver conditions affecting immune response
A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic
![20210603 Guidelines comparison table [online]](https://d3j7puhwqgd8ts.cloudfront.net/Pictures/100x67//0/0/0/10000_20210603guidelinescomparisontableonline_766677.png)
